Future studies that determine whether this novel PRC2 regulatory function causes DNA hypermethylation in cancers with mutations that deplete genomic H3K27me3, such as H3.3 K27M mutant glioblastomas or myeloid leukemias and lymphomas with EZH2 loss of function mutations, are clearly warranted. Here, EZH2 is linked to myeloid leukemia.